|
| Current Location：Home > Information > Enterprise Alerts |
| Responsibility for quality control of essential drugs to enhance the book signing in Beijing |
May 22, 2010, to implement the State Council's 2010 annual work plans of medical reform, strengthen the quality control of essential drugs, the State Food and Drug Administration held in Beijing to strengthen quality control of essential drugs work conference. At the meeting, the State Food and Drug Administration Shao Mingli behalf of the State Council signed with the provincial bureau of quality essential drugs to strengthen supervision of the major tasks for the year 2010, letters of responsibility.
Responsibilities involve a total of nine aspects, including the full increase and improve the quality of 307 kinds of standard essential medicines; the strengthening of the regulatory aspects of drug production, organizations within the area of essential drugs manufacturers of prescription and process verification, monitoring files varieties of essential medicines ; to enhance drug delivery and use of part of the basic regulation, the relevant distribution company, and primary care health supervision institutions to do the whole cover, no missing, establish a basic drug delivery enterprise database; strengthen basic adverse drug reaction monitoring and evaluation, implementation of adverse drug reaction monitoring of network management; of basic drugs covering all varieties of testing, all varieties of electronic supervision.
It is understood that since last year, the national food and drug supervision system to build the system, laying the foundation, strong grass-roots focus on steps to enhance the quality of supervision of essential drugs. Basic drug production enterprises carried out investigations to find out the regulatory know the truth. Completed the implementation of the basic drugs on the quality and safety, and pharmaceutical manufacturing business impact assessment. Assessment of quality standards for essential drugs, initially to establish basic standards for drug evaluation and testing to improve the linkage mechanism. The establishment of essential drugs to enhance the quality of the regulatory system, the completion of the medical reform package file "on the strengthening of the supervision and management of drug quality requirements." Provinces (regions, municipalities) actively participates in the medical reform work, combined with local realities, to explore new mechanisms for monitoring and new methods.
Shao Mingli at the meeting pointed out that in 2010, food and drug supervision system to strengthen quality control of essential drugs work tasks are arduous. The whole system down to confidence, unity of thinking, awareness, a solid grasp supervision, to ensure that essential drugs quality and safety.
Shao pointed out that the current and future period of time, in deepening medical reform in the process of food and drug regulatory departments of the central task and key work is to strengthen the monitoring of essential drugs, basic medicines to ensure quality and safety. This is also the food and drug regulatory system, implement the scientific concept of development, practice the scientific concept of regulation to protect people's basic drug benefits, to realize, safeguard and develop the fundamental interests of the masses embodiment. Medical reform is a new topic, new tasks, are bound to hold the Food and Drug Administration new opportunities for career development. Can be said that health care reform is to strengthen the government responsibility to promote the overall responsibility of local governments the opportunity of drug safety; improve the regulatory environment, the implementation of the first responsible person liability company opportunity; is to strengthen drug regulation, improve food and drug regulatory capacity and level of opportunity . Food and drug supervision departments should seize the opportunity to effectively promote the implementation of the basic responsibility of drug safety, regulatory innovation in advancing new progress.
Shao Mingli stressed that food and drug regulatory departments at all levels to ensure the quality, complete with regulatory mandates. Food and drug regulatory authorities involved in medical reform, we should always ensure that the drugs, in particular the quality of essential drugs on the center. Around the tasks in the overall consideration of inputs and human resources based on the special emphasis on work to the grassroots, to the allocation of resources to the grassroots level, so that specific work and organizations, positions, personnel combine to promote medical reform in the process strengthen the primary regulatory power. To strengthen communication and coordination with relevant departments, to grasp the situation, create a good working environment.
State Food and Drug Administration, Wu Zhen, deputy director of the Chair, the Deputy Secretary Li Jiping, side Zhenjia attended the meeting. 31 provinces (autonomous regions and municipalities) and cities, sub-provincial capital cities and Xinjiang Production and Construction Corps, responsible for food and drug regulatory departments under the State Council is responsible for the relevant departments of related people attended the meeting.
Enhance the quality of essential drugs forum site supervision
State Food and Drug Administration, Shao Mingli (left) and Tianjin Food and Drug Administration signed letters of responsibility the Secretary Wang Shengtian
|
| AddTime：2010-5-24 13:04:21 |
Hits：207 |
[Back] |
|
|
|
|
